BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 1365448)

  • 1. Embryonic dopaminergic neuron transplants in MPTP lesioned mouse striatum.
    Di Porzio U; Zuddas A
    Neurochem Int; 1992 Mar; 20 Suppl():309S-320S. PubMed ID: 1365448
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Specific Reinnervation of Lesioned Mouse Striatum by Grafted Mesencephalic Dopaminergic Neurons.
    Zuddas A; Corsini GU; Barker JL; Kopin IJ; Di Porzio U
    Eur J Neurosci; 1991 Oct; 3(1):72-85. PubMed ID: 12106271
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dopaminergic transplants normalize amphetamine- and apomorphine-induced Fos expression in the 6-hydroxydopamine-lesioned striatum.
    Cenci MA; Kalén P; Mandel RJ; Wictorin K; Björklund A
    Neuroscience; 1992; 46(4):943-57. PubMed ID: 1347413
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anatomical and functional reconstruction of the nigrostriatal pathway by intranigral transplants.
    Gaillard A; Decressac M; Frappé I; Fernagut PO; Prestoz L; Besnard S; Jaber M
    Neurobiol Dis; 2009 Sep; 35(3):477-88. PubMed ID: 19616502
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evidence for target-specific nerve fiber outgrowth from subpopulations of grafted dopaminergic neurons: a retrograde tracing study using in oculo and intracranial grafting.
    Törnqvist N; Björklund L; Strömberg I
    Exp Neurol; 2001 Jun; 169(2):329-39. PubMed ID: 11358446
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Restoration of dopamine transporter density in the striatum of fetal ventral mesencephalon-grafted, but not sham-grafted, MPTP-treated parkinsonian monkeys.
    Elsworth JD; Brittan MS; Taylor JR; Sladek JR; al-Tikriti MS; Zea-Ponce Y; Innis RB; Redmond DE; Roth RH
    Cell Transplant; 1996; 5(2):315-25. PubMed ID: 8689042
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The age of striatum determines the pattern and extent of dopaminergic innervation: a nigrostriatal double graft study.
    Strömberg I; Björklund L; Förander P
    Cell Transplant; 1997; 6(3):287-96. PubMed ID: 9171161
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Early and widespread normalization of dopamine-neuropeptide Y interactions in the rat striatum after transplantation of fetal mesencephalon cells.
    Moukhles H; Nieoullon A; Daszuta A
    Neuroscience; 1992; 47(4):781-92. PubMed ID: 1349734
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The neurotoxin MPTP causes degeneration of specific nucleus A8, A9 and A10 dopaminergic neurons in the mouse.
    German DC; Nelson EL; Liang CL; Speciale SG; Sinton CM; Sonsalla PK
    Neurodegeneration; 1996 Dec; 5(4):299-312. PubMed ID: 9117541
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Behavioral and electrophysiological correlates of human mesencephalic dopaminergic xenograft function in the rat striatum.
    van Horne CG; Mahalik T; Hoffer B; Bygdeman M; Almqvist P; Stieg P; Seiger A; Olson L; Strömberg I
    Brain Res Bull; 1990 Aug; 25(2):325-34. PubMed ID: 1977499
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fetal ventral mesencephalic grafts functionally reduce the dopamine D2 receptor supersensitivity in partially dopamine reinnervated host striatum.
    Strömberg I; Kehr J; Andbjer B; Fuxe K
    Exp Neurol; 2000 Jul; 164(1):154-65. PubMed ID: 10877926
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long distance directed axonal growth from human dopaminergic mesencephalic neuroblasts implanted along the nigrostriatal pathway in 6-hydroxydopamine lesioned adult rats.
    Wictorin K; Brundin P; Sauer H; Lindvall O; Björklund A
    J Comp Neurol; 1992 Sep; 323(4):475-94. PubMed ID: 1358925
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased vulnerability of dopaminergic neurons in MPTP-lesioned interleukin-6 deficient mice.
    Bolin LM; Strycharska-Orczyk I; Murray R; Langston JW; Di Monte D
    J Neurochem; 2002 Oct; 83(1):167-75. PubMed ID: 12358740
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evidence for target-specific outgrowth from subpopulations of grafted human dopamine neurons.
    Strömberg I; Törnqvist N; Johansson S; Bygdeman M; Almqvist PM
    Microsc Res Tech; 2001 Sep; 54(5):287-97. PubMed ID: 11514985
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Selective lesion of the nigrostriatal dopaminergic pathway by MPTP and acetaldehyde or diethyldithiocarbamate.
    Zuddas A; Vaglini F; Fornai F; Corsini GU
    Neurochem Int; 1992 Mar; 20 Suppl():287S-293S. PubMed ID: 1365444
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reconstruction of the striato-nigro-striatal circuitry by simultaneous double dopaminergic grafts: a tracer study using fluorogold and horseradish peroxidase.
    Mendez I; Hong M
    Brain Res; 1997 Dec; 778(1):194-205. PubMed ID: 9462892
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Autoradiographic study of striatal dopamine re-uptake sites and dopamine D1 and D2 receptors in a 6-hydroxydopamine and quinolinic acid double-lesion rat model of striatonigral degeneration (multiple system atrophy) and effects of embryonic ventral mesencephalic, striatal or co-grafts.
    Puschban Z; Scherfler C; Granata R; Laboyrie P; Quinn NP; Jenner P; Poewe W; Wenning GK
    Neuroscience; 2000; 95(2):377-88. PubMed ID: 10658617
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Time-course of recovery of dopamine neuron activity during reinnervation of the denervated striatum by fetal mesencephalic grafts as assessed by in vivo voltammetry.
    Forni C; Brundin P; Strecker RE; el Ganouni S; Björklund A; Nieoullon A
    Exp Brain Res; 1989; 76(1):75-87. PubMed ID: 2502425
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased survival of dopaminergic neurons in striatal grafts of fetal ventral mesencephalic cells exposed to neurotrophin-3 or glial cell line-derived neurotrophic factor.
    Espejo M; Cutillas B; Arenas TE; Ambrosio S
    Cell Transplant; 2000; 9(1):45-53. PubMed ID: 10784066
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epidermal growth factor enhances striatal dopaminergic parameters in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated mouse.
    Hadjiconstantinou M; Fitkin JG; Dalia A; Neff NH
    J Neurochem; 1991 Aug; 57(2):479-82. PubMed ID: 1677029
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.